Showing results (51-60 of 555) with videos related to

Sort By:
Pageof 56
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|January 22, 2019
Hormonal contraception in women with endometriosis: a systematic reviewGiovanni Grandi, Fabio Barra, Simone Ferrero, et al.
Ecancermedicalscience|May 19, 2020
Borderline ovarian tumours: management in the era of fertility-sparing surgeryMattia Maramai, Fabio Barra, Mario Valenzano Menada, et al.
Journal of Gynecology Obstetrics and Human Reproduction|April 10, 2020
Endometrial scratching for infertility: The never-ending storyAmerigo Vitagliano, Salvatore Giovanni Vitale, Antonio Cianci, et al.
Expert Opinion on Pharmacotherapy|February 11, 2020
Advances in paclitaxel combinations for treating cervical cancerLuigi Della Corte, Fabio Barra, Virginia Foreste, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 14, 2017
Impact of large ovarian endometriomas on the response to superovulation for in vitro fertilization: A retrospective studySimone Ferrero, Carolina Scala, Emanuela Tafi, et al.
Acta Obstetricia Et Gynecologica Scandinavica|December 31, 2013
Desogestrel-only contraceptive pill versus sequential contraceptive vaginal ring in the treatment of rectovaginal endometriosis infiltrating the rectum: a prospective open-label comparative studyUmberto Leone Roberti Maggiore, Valentino Remorgida, Carolina Scala, et al.
Expert Opinion on Drug Safety|August 11, 2025
Safety of current strategies to manage moderate to severe pain in patients with endometriosisSimone Ferrero, Fabio Barra, Giulia Vatteroni, et al.
Expert Opinion on Investigational Drugs|March 10, 2017
Investigational drugs for the treatment of cervical cancerFabio Barra, Domenica Lorusso, Umberto Leone Roberti Maggiore, et al.
Expert Opinion on Pharmacotherapy|June 10, 2026
Role of hormonal therapies in endometriosis: balancing efficacy and safetySimone Ferrero, Michele Paudice, Umberto Perrone, et al.
Expert Opinion on Investigational Drugs|June 17, 2020
Prexasertib: an investigational checkpoint kinase inhibitor for the treatment of high-grade serous ovarian cancerGiulio Evangelisti, Fabio Barra, Melita Moioli, et al.
Pageof 56